Health In Tech, Inc. (HIT)

Health In Tech Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	22.38	19.49	19.15	5.77
Revenue Growth (YoY)	11.24%	1.77%	231.93%	-
Cost of Revenue	5.72	4.05	2.3	0.33
Gross Profit	16.66	15.44	16.85	5.44
Selling, General & Admin	12.93	11.64	11.46	4.44
Research & Development	2.59	2.81	2	0.79
Operating Expenses	15.52	14.45	13.46	5.23
Operating Income	1.14	0.99	3.38	0.21
Interest Expense	-0.33	-0.5	-0	-0
Interest & Investment Income	0.18	0.12	0.04	-
Other Non Operating Income (Expenses)	0.39	0.27	-	-
Pretax Income	1.38	0.89	3.42	0.2
Income Tax Expense	0.31	0.22	0.95	0.12
Earnings From Discontinued Operations	-	-	1.48	-0.32
Net Income to Company	1.07	0.67	3.96	-0.24
Minority Interest in Earnings	-	-	-1.48	0.32
Net Income	1.07	0.67	2.48	0.08
Net Income to Common	1.07	0.67	2.48	0.08
Net Income Growth	-40.52%	-72.93%	3005.84%	-
Shares Outstanding (Basic)	53	52	52	48
Shares Outstanding (Diluted)	55	54	52	48
Shares Change (YoY)	6.18%	3.66%	7.54%	-
EPS (Basic)	0.02	0.01	0.05	0.00
EPS (Diluted)	0.02	0.01	0.05	0.00
EPS Growth	-47.26%	-79.10%	2788.89%	-
Gross Margin	74.44%	79.21%	87.97%	94.21%
Operating Margin	5.08%	5.08%	17.66%	3.56%
Profit Margin	4.77%	3.44%	12.93%	1.38%
EBIT	1.14	0.99	3.38	0.21
EBIT Margin	5.08%	5.08%	17.66%	3.56%
Effective Tax Rate	22.66%	24.58%	27.62%	60.33%
Revenue as Reported	22.38	19.49	19.15	5.77
Advertising Expenses	-	0.06	0.31	0.11

Updated Mar 17, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q